Gómez Córdoba Ana Isabel
Universidad del Rosario, Bogotá, Colombia.
Rev Derecho Genoma Hum. 2011 Jul-Dec(35):183-223.
Deciphering the human genome has allowed the development of new health care ways which have been generically referred to as genomic medicine. However, this new knowledge is not devoid of risks related to the access and use of genetic information, involving not only the individual, but also the biological family, ethnic group and community to which he/she belong to. This affects both individual and collective rights, which must be protected by law. This manuscript reviews the Colombian law, specifically in terms of the access and use of genetic information for diagnostic and treatment purposes, focusing on the informed consent process. The concept of genetic information, the risks and benefits associated with genetic data management and the description and critical analysis of the present Colombian regulations were thus reviewed. As a conclusion, the juridical framework of Colombia shows deficiencies regarding the protection of both individual and collective rights linked to the access and use of genetic information.
解读人类基因组使得新的医疗保健方式得以发展，这些方式被统称为基因组医学。然而，这一新知识并非没有与获取和使用遗传信息相关的风险，这不仅涉及个人，还涉及其所属的生物家族、族群和社区。这影响到个人权利和集体权利，必须通过法律加以保护。本手稿回顾了哥伦比亚法律，特别是在出于诊断和治疗目的获取和使用遗传信息方面，重点关注知情同意过程。因此，对遗传信息的概念、与遗传数据管理相关的风险和益处以及现行哥伦比亚法规的描述和批判性分析进行了回顾。结论是，哥伦比亚的法律框架在保护与获取和使用遗传信息相关的个人权利和集体权利方面存在缺陷。
